Previous symbols: AMPHL. Aliases: SH3P9, AMPH2.
BIN1 encodes amphiphysin II, a BAR/N-BAR and SH3-domain membrane-remodeling adaptor with extensive alternative splicing in brain and skeletal muscle. BIN1 binds phospholipid membranes, senses and generates membrane curvature, promotes lipid tubulation, and organizes membrane domains used in endocytosis, synaptic-vesicle cycling, endosomal sorting, and skeletal-muscle T-tubule formation. Through SH3-domain interactions with endocytic proteins such as dynamin and clathrin/AP2-associated machinery, BIN1 links curved membranes to vesicle trafficking and cytoskeletal organization. Additional context-specific functions include nuclear/MYC-related tumor-suppressor activities, tau and clusterin interactions, and regulation of BACE1 trafficking and amyloid-beta production.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Centronuclear Myopathy | causative |
mechanism: BIN1 amphiphysin-2 dysfunction
subtype: BIN1-CNM
scoped to subtype: BIN1-CNM
|
| Alzheimer Disease |
untyped
Risk Factor
|
scoped to subtype: Late-Onset Alzheimer's Disease
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| centronuclear myopathy MONDO:0018947 | AD | Limited 2024-06-10 |
Centronuclear Myopathy
causative
|
| centronuclear myopathy MONDO:0018947 | AR | Definitive 2024-06-10 |
Centronuclear Myopathy
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.